Table 1: Gene targeting drugs.
BRAF inhibitors MEK inhibitors Kit inhibitors PI3K Inhibitors Mammalian target of
rapamycin (m-TOR) inhibitors |
Vemurafenib, Dabrafenib, Encorafenib Trametinib, Selumetinib,
Cobimetinib Imatinib,
Sunitinib, Nilotinib, Dasatinib, Masitinib LY294002, Wortmannin Rapamycin |
PI3K: phosphatidylinositol 3-kinase